Judson I - Search Results

1

The proteomic landscape of soft tissue sarcomas.

Burns J, Wilding CP, Krasny L, Zhu X, Chadha M, Tam YB, Ps H, Mahalingam AH, Lee ATJ, Arthur A, Guljar N, Perkins E, Pankova V, Jenks A, Djabatey V, Szecsei C, McCarthy F, Ragulan C, Milighetti M, Roumeliotis TI, Crosier S, Finetti M, Choudhary JS, Judson I, Fisher C, Schuster EF, Sadanandam A, Chen TW, Williamson D, Thway K, Jones RL, Cheang MCU, Huang PH. Burns J, et al. Among authors: judson i. Nat Commun. 2023 Jun 29;14(1):3834. doi: 10.1038/s41467-023-39486-2. Nat Commun. 2023. PMID: 37386008 Free PMC article.

2

The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.

Verrill MW, Judson IR, Wiltshaw E, Thomas JM, Harmer CL, Fisher C. Verrill MW, et al. Among authors: judson ir. Ann Oncol. 1997 Nov;8(11):1099-105. doi: 10.1023/a:1008264902857. Ann Oncol. 1997. PMID: 9426329 Free article.

3

Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.

Coley HM, Verrill MW, Gregson SE, Odell DE, Fisher C, Judson IR. Coley HM, et al. Among authors: judson ir. Eur J Cancer. 2000 May;36(7):881-8. doi: 10.1016/s0959-8049(00)00032-0. Eur J Cancer. 2000. PMID: 10785593

4

Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.

Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Spillane AJ, et al. Among authors: judson ir. J Clin Oncol. 2000 Nov 15;18(22):3794-803. doi: 10.1200/JCO.2000.18.22.3794. J Clin Oncol. 2000. PMID: 11078492

5

A gene expression signature associated with metastatic outcome in human leiomyosarcomas.

Lee YF, John M, Falconer A, Edwards S, Clark J, Flohr P, Roe T, Wang R, Shipley J, Grimer RJ, Mangham DC, Thomas JM, Fisher C, Judson I, Cooper CS. Lee YF, et al. Among authors: judson i. Cancer Res. 2004 Oct 15;64(20):7201-4. doi: 10.1158/0008-5472.CAN-04-1673. Cancer Res. 2004. PMID: 15492233

6

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.

Spurrell EL, Fisher C, Thomas JM, Judson IR. Spurrell EL, et al. Among authors: judson ir. Ann Oncol. 2005 Mar;16(3):437-44. doi: 10.1093/annonc/mdi082. Epub 2005 Jan 14. Ann Oncol. 2005. PMID: 15653701 Free article.

7

The development and application of imatinib.

Jones RL, Judson IR. Jones RL, et al. Expert Opin Drug Saf. 2005 Mar;4(2):183-91. doi: 10.1517/14740338.4.2.183. Expert Opin Drug Saf. 2005. PMID: 15794712 Review.

8

Soft-tissue sarcomas in adults.

Clark MA, Fisher C, Judson I, Thomas JM. Clark MA, et al. Among authors: judson i. N Engl J Med. 2005 Aug 18;353(7):701-11. doi: 10.1056/NEJMra041866. N Engl J Med. 2005. PMID: 16107623 Review. No abstract available.

9

Differential sensitivity of liposarcoma subtypes to chemotherapy.

Jones RL, Fisher C, Al-Muderis O, Judson IR. Jones RL, et al. Eur J Cancer. 2005 Dec;41(18):2853-60. doi: 10.1016/j.ejca.2005.07.023. Epub 2005 Nov 10. Eur J Cancer. 2005. PMID: 16289617

10

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

Karavasilis V, Seddon BM, Ashley S, Al-Muderis O, Fisher C, Judson I. Karavasilis V, et al. Among authors: judson i. Cancer. 2008 Apr 1;112(7):1585-91. doi: 10.1002/cncr.23332. Cancer. 2008. PMID: 18278813 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

392 results

Search Page